Skip to main content
. Author manuscript; available in PMC: 2016 Aug 17.
Published in final edited form as: JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207–1217. doi: 10.1016/j.jcin.2015.04.018

Figure 2. Adjusted between group differences in generic health status between TAVR and AVR, based on longitudinal growth curve models.

Figure 2

Figure 2

Figure 2

Figure 2

Results are reported separately for the iliofemoral (blue circles) and non-iliofemoral (red squares). Error bars denote 95% confidence intervals. P values are for the interaction between treatment group and access site at each time point.